Status
Conditions
Treatments
About
Potential participants will be screened at clinic. Patients who meet eligibility criteria will be considered for study. After written informed consent is obtained, participants will complete baseline testing and participants who meet eligibility criteria will be randomized 1:1 to 2 treatment arms: Vivo Arm: Vivo twice a week for 6 months and Usual Care Arm: meet with ATC and given Medbridge home exercise program for 6 months. All participants will be followed for 12 months, and will be assessed at 3-,6-, and 12-months. All participants will complete functional assessments, OA patient reported outcomes measures, quality of life, exercise self-efficacy, and fall risk questionnaires, and health care utilization report at each testing visit. A subset of Vivo participants will be asked satisfaction questions at the 3 and 6 month time points.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
55-85 years of age
Diagnosis of Osteoarthritis within the prior 6 months
Symptomatic OA defined as self-report:
Pain in the knee(s) on most days of the month
Difficulty with at least one of the following because of knee pain:
Radiographic KL grade II-III (using Kellgren and Lawrence criteria) of one or both knees
Physically able to participate in strength training - able to do one chair stand unassisted in order to test change in 30-second chair stand
Ambulatory and community-dwelling
Sedentary or insufficiently active as measured by the PAVS
Access to Wi-Fi in defined exercise space
BMI of 20-34.9 kg/m2
Document medication specific to OA and knee pain
Willing and able to provide consent
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
334 participants in 2 patient groups
Loading...
Central trial contact
Amelia Millward
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal